Name: International conference on Tropical and Infectious Diseases
Start: 2020-10-15
End: 2020-10-17
Location: Paris

- Quick Links -

Performers / Professionals From Around The Globe

Tracks & Key Topics

Tracks

Academic Key Topics

Business Key Topics

ABOUT CONFERENCE

Euroscicon Conferences takes an immense Pleasure to invite participants from all over the world to attend the " International conference on Tropical and Infectious Diseases”, to be held Online on October15-16, 2020. The conference program focuses on “Prevention on infectious diseases and study of covid-19”. This gathering will strengthen the ideas about infectious Diseases and different aspects related to it. We attempt to provide a perfect stage to Researchers, Scholars, and key Speakers to share data and experiences and empower people with their deep knowledge of Human Infectious Diseases and aspire them to fight against the worldwide risk related to it. The convention meeting consists of discussion and workshops, keynote speeches, absolute talks, poster presentations, e-Poster introductions and a panel session on cutting-edge research traits within the field of Infectious diseases , Prevention, Control and Diagnosis of emerging Diseases. Tropical Diseases 2020 is the only meeting where you can learn about Infectious Diseases from a variety of perspectives, both research-based and clinical. We will discuss the newest therapeutic techniques and diagnostic tools as well as the most up-to-date research on genetic, etiology, diagnostic, clinical aspects and novel therapies of Infectious diseases. Global Infections Conferences provides the time to collaborate with industry peers and discover knowledge and resources that can be used to achieve your personal and organizational goals. Infectious diseases meet incorporates, visitor addresses, keynotes, symposiums, workshops, presentations, board talks, poster sessions, and various summits for the all over participants. This meeting will unite many representatives which include worldwide Specialists, Researchers, Analysts, Understudies, Nurses, Exhibitors, Investigators, Microbiologists, Pathologists, Pharmacists, Professors and Industrial Pharmaceuticals and Business delegates everywhere in the globe to connect us on October 2020 for the 2-day Tropical Diseases meet.

Sessions and Tracks

Track 1: Clinical Immunology and Allergy Clinical Immunology is associated with the study of diseases which are caused due to disorders of immune system i.e., abnormal growth of any cellular tissues of the system, hypersensitivities such as asthma, immune system failure and other allergies. Some of the immune diseases include autoimmune disease, hypersensitivity, immune disorder and immunodeficiency.

An allergic disease occurs when a person immune system reacts to substances present in the environment that are harmless for most people. These substances are known as allergens and are found in dust mites, pets, pollen, insects, ticks, moulds, foods and some medications. Some of the allergies include drug allergy, food allergy, insect allergy, latex allergy, mold allergy, pet allergy and pollen allergy.

Track 2: Pediatric Infectious Diseases

Pediatric Critical Care Medicine is the official journal of the Society of Critical Care Medicine, the World Federation of Pediatric infectious diseases and Critical Care Societies, the Pediatric Intensive Care Society UK, the Latin American Society of Pediatric Intensive Care, and the Japanese Society of Pediatric Intensive and Critical Care. This exciting journal is the first scientific, peer-reviewed publication to focus exclusively on Pediatric Critical Care Medicine and critical care neonatology.

Pediatric infectious diseases is written for the entire Pediatric Infectious Diseases team: pediatricians, neonatologists, respiratory therapists, nurses, and others who deal with pediatric patients who are critically ill or injured. International in scope, with editorial board members and contributors from around the world, the Journal includes a full range of scientific content, including clinical articles, scientific investigations, solicited reviews, and abstracts from pediatric critical care meetings. Additionally, the Journal includes abstracts of selected articles published in Chinese, French, Italian, Japanese, Portuguese, and Spanish translations - making news of advances in the field available to pediatric and neonatal intensive care practitioners worldwide.

Track 3; HIV/AIDS and Sexually Transmitted Infections

Treatment and prevention of HIV and sexually transmitted infections should be priorities for health systems around the world. Untreated or undertreated STIs can lead to infertility, cancer, chronic pelvic pain, and facilitate HIV transmission. New and existing treatments, tests and prevention strategies therefore need to be rigorously evaluated to assess their benefits and harms as this information is important for clinical decision-making and policy and guideline development. This note introduces the new Sexually Transmitted Infections Cochrane Review group, which aims to support authors in summarising evidence about interventions and diagnostic tests used for genital tract infections.

Track 4: Infectious Diseases and Cancer.

The status of the immune system affects and is affected by both cancer and chronic infection. Some molecular mechanisms of immunity are relevant to both disease states. The role of infectious agents in cancer is generally underappreciated. However, approximately 20% of human cancers are caused by infectious agents and as such they rank second only to tobacco as a potentially preventable cause in humans. Specific viruses, parasites, and bacteria have been linked to specific human cancers. The infectious ethology for these specific cancers provides opportunities for prevention and treatment. The mechanisms by which an infectious agent can cause a cancer to vary. Some infectious agents that cause persistent infection and chronic inflammation lead to the formation of reactive oxygen and nitrogen species by macrophages at the site of the infection leading in turn to cell damage and cellular proliferation.

Track 5: Gastrointestinal Infections

The topic of Gastrointestinal Infections is completely reliable to the source of information on the discoveries and current developments in the form of Gastrointestinal Infections. Gastrointestinal infections are viral, bacterial or parasitic infections that cause gastroenteritis, an inflammation of the gastrointestinal tract involving both the stomach and the small intestine. Symptoms include diarrhea, vomiting, and abdominal pain. Dehydration is the main danger of gastrointestinal infection In all areas of the gastro-intestinal infections like constipation, making them freely available worldwide.

Tack 6: Tropical Medicine

Tropical medicine encompasses a diverse group of issues related to infectious diseases (viral, bacterial, parasitic and fungal infections), non-communicable diseases and malnutrition with its consequences. Physicians in this field diagnose and treat a variety of diseases and ailments. Lack of availability of clean water and food made with unhygienic practices add to the morbidity of these diseases. The tropics are reeling under the onslaught of climate change, deforestation, and air, water, and soil pollution, which worsens an already fragile health system.

Track 7: Neglected Tropical Diseases

Neglected tropical diseases (NTDs) represent a group of diverse diseases that cause significant morbidity and mortality worldwide but have until recently received limited attention from the affluent regions of the world. More than 1 billion people – one-sixth of the world’s population – suffer from one or more NTDs. These diseases affect the world’s most v ulnerable populations, almost exclusively poor and powerless people living in rural areas and urban slums of low-income countries. Their impact on individuals and communities is devastating. Many of them cause severe disfigurement and disabilities, including blindness.
NTDs coexist with poverty because they thrive where access to clean water and sanitation is limited, and people live without protection from disease vectors. The NTDs also are recognized as a contributor to poverty since they can impair intellectual development in children, reduce school enrolment and hinder economic productivity by limiting the ability of infected individuals to work.

Track 8: Tropical Diseases in Animals

Incidents of animal or plant disease are not solely natural occurrences. Human actions are extensively implicated in the spread and outbreak of disease. In turn, disease affects human interests widely, and much effort is spent in the control of disease. Consequently, it is difficult to prise apart the natural phenomena of disease and the social phenomena of the drivers, impacts and regulation of disease. Reframing the key issues through incorporating both social and natural science research can provide a holistic understanding of disease and increase the policy relevance and impact of research.

Track 9: Sexually Transmitted Diseases

Sexually transmitted diseases (STDs) are a major health problem affecting mostly young people .The goal of the STAR Sexually Transmitted Infection Clinical Trial Group Programmatic meeting on Sexually Transmitted Infections in Pregnancy and Reproductive Health, nonprofit, and industry discussed the burden of STIs during pregnancy; the impact of STIs on adverse pregnancy and birth outcomes; interventions that work to reduce STIs in pregnancy, and the evidence, policy, and technology needed to improve STI care during pregnancy.

Track 10: Natural Disasters

Natural disasters are increasing in their frequency and complexity. Understanding how their cascading effects can lead to infectious disease outbreaks is important for developing cross-sectoral preparedness strategies.

Track 11: Infectious Agents and the Human Immune Response

Immune response plays a vital role in protecting against infectious agents. It is the main impediment against the occurrence of disseminated infections that are usually associated with a high death rate. It is a well-known fact that for virtually all infectious diseases, the number of individuals exposed to infection is much higher than those actually presenting with a disease. This indicates that most persons are able to destroy these microorganisms and thus prevent the progression of an infection. By contrast immune deficiencies, whether of innate immunity (phagocytic cell dysfunction or complement deficiency) or adaptive immunity is strongly associated with increased susceptibility to infections.

Although immune response is fundamental for protecting against most infectious agents, evidence has been accumulating over the years as to how in many infectious diseases the main pathological aspects are not related to the direct action of an aggressor agent, but instead to abnormal immune response.

Track 12: Emerging infectious diseases

The relationship between natural disasters and emerging diseases is frequently misconstrued. The risk for outbreaks is often presumed to be very high in the chaos that follows natural disasters, a fear likely derived from a perceived association between dead bodies and epidemics. The recent resurgence of infectious disease mortality marks a third epidemiologic transition characterized by newly emerging, re- emerging, and antibiotic resistant pathogens in the context of an accelerated globalization of human disease ecologies. These transitions illustrate recurring sociohistorical and ecological themes in human–disease relationships from the Palaeolithic Age to the present day.

Track 13: Pediatric Infectious Diseases/ Childhood Infectious Diseases

Every day, children are exposed to a variety of germs that may cause infectious diseases.

Preventing infectious diseases today is much easier than in the past, thanks to improved hygiene practices, better vaccines and advances in medical technology. However, there are still common and unusual infections that children contract. Some of these can be difficult to diagnose or difficult to treat. Infections in high-risk patients, including those with compromised immune systems, cancer, prematurity and children with pulmonary, cardiac or renal disease.

Track 14: Dermatological Infectious Diseases

Skin is the body's largest organ. It has many different functions, including covering and protecting the body. It helps keep germs out. But sometimes the germs can cause a skin infection. This often happens when there is a break, cut, or wound on skin. It can also happen when the immune system is weakened, because of another disease or a medical treatment. Some skin infections cover a small area on the top of skin. Other infections can go deep into the skin or spread to a larger area. The role of other infectious diseases within dermatology, however, has remained strong. Many infectious diseases such as human papillomavirus, tinea, herpes, measles, varicella and impetigo have primary skin manifestations.

Track 15: Infectious Diseases in Obstetrics and Gynecology

Infection is a leading cause of mortality and morbidity in neonates, with group B streptococcus (GBS) remaining the most frequent pathogen isolated from term infants. Prevention strategies based on universal screening and intrapartum chemoprophylaxis to reduce vertical transmission of invasive GBS disease in at-risk women resulted in substantial reduction in early-onset GBS disease. The Centers for Disease Control and Prevention (CDC) recommended universal antenatal screening at 35 to 37 weeks of pregnancy and intrapartum chemoprophylaxis to all GBS-colonized women at the time of labor or premature rupture of membranes (PROM) including women planning delivery by cesarean section. The only exception was for GBS-colonized women who have a planned cesarean delivery prior to the onset of labor or PROM.

Track 16: Dental and Oral Infectious Diseases

Oral infections are some of the most common diseases in humans. The two most common oral infections are caries and periodontal disease. Dental caries is the most common chronic disease of childhood and is the biggest unmet health care need among America’s children. Periodontal disease is the most common infectious disease of adults. At least 1/3 of the population is affected by chronic periodontitis, a bacterially induced destruction of the attachment of the tooth to bone. Research is focused on understanding the etiology of these complex diseases and identifying new therapies. We are also interested in the interaction of oral pathogens with host tissues. Oral conditions such as burning mouth syndrome or the removal of 3rd molars can impact the sense of taste. Taste also contributes to our quality of life. People spend countless hours and financial resources eating and exploring new cuisines.

Track 17: Gastrointestinal & Urinary Tract Infections

Gastrointestinal & Urinary Tract Infections are among the most commonly encountered infections in primary care. While they may not always be severe and may often resolve rapidly, they can be serious in specific healthcare settings or patient populations. Gastrointestinal infections are viral, bacterial or parasitic infections that cause gastroenteritis, an inflammation of the gastrointestinal tract involving both the stomach and the small intestine. Symptoms include diarrhoea, vomiting, and abdominal pain. Dehydration is the main danger of gastrointestinal infections, so rehydration is important, but most gastrointestinal infections are self-limited and resolve within a few days.

Track 18: Urinary tract infections and Gynecology

Urinary tract infections (UTIs) are a common medical complaint. It is estimated that up to 40 percent of women will have a UTI at some time in their lives. Also called bladder infections or cystitis, a UTI occurs when bacteria enter the bladder, usually through the urethra (urine tube), and begin to multiply. Urine contains fluids, salts and waste products but is sterile or free of bacteria, viruses and other disease-causing organisms. A UTI occurs when bacteria from another source, such as the nearby anus, gets into the urethra. The most common bacteria found to cause UTIs is Escherichia coli (E. coli). Other bacteria can cause UTI, but E. coli is the culprit about 90 percent of the time.

Track 19: Information Technology and Innovation in Infectious Diseases

Implement innovation and access to health technologies remains a key strategy in combating infectious diseases in low- and middle-income countries (LMICs). However, a gulf between paying markets and the endemicity of such diseases has contributed to the dearth of R&D in meeting these public health needs. Facing such resource constraints, LMICs are poised to develop a new, more resource-effective model of innovation that holds exciting promise in meeting the needs of global health.

Track 20: Types of Infections

Bacterial infections
Lyme disease
Fungal infections
Parasitic infections
Symptoms of infection
From an infected animal

Market Ananlysis

The market size for microbiology valued at USD 9.1 billion in 2016 and is expected to develop at a CAGR of 6.7% over the forecast period. Constantly rising of infectious diseases is driving market growth.

Infectious diseases are primarily diagnosed by using clinical tests. According to the Centres for Disease Control and Prevention(CDC), around 9,421 new cases of tuberculosis, 51,455 new cases of salmonella, 33,461 new cases of Lyme disease, and in 2014, 433 new cases of meningococcal disease were registered in U.S.

According to the American Cancer Society, 1,688,780 new cases of cancer were diagnosed in U.S. in 2017. Clinical tests are made as one of the major diagnostic tools is expected to augment market growth in future. Sudden outbreaks of Ebola, Zika, and other contagious diseases are also contributing to rising prevalence of infectious diseases.

Conference Image

Product Insights:

Reagents accounted for the global revenue share in the clinical microbiology market. This segment includes products such as solutions, primers, master mixes, and kits used in various diagnostic assays. Reagents currently takes the largest revenue share, with more than 60% attributed to repeat purchase driven by need for new set of reagents for new tests.

This segment is expected to remain dominant throughout the forecast period. Factors such as higher cost of specialized kits and constant repeat purchase are expected to drive the segment over the forecast period. The market is witnessing rising investments in research and development (R&D). Almost all analytical and therapeutic research projects demand reagents and chemicals, thereby driving penetration of reagents.